Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Inflation Reduction Act (IRA) boosts biological drugs

<< Previous

Bullboard Posts

Next >>

Comment by Noteableon Mar 19, 2024 5:43pm

74 Views

Post# 35941690

RE:RE:RE:RE:RE:RE:Inflation Reduction Act (IRA) boosts biological drugs

MARCH 18, 2024 - The BIOSECURE Act: Proposed New Legislation Could Affect U.S. Companies’ Plans to Contract With Chinese Biotechnology Companies

- By James C. Shehan and Daniel C. Porco

" The Biosecure Act would prohibit all executive agencies from contracting with or extending loans or grants to any company with current or future commercial arrangements with a “biotechnology company of concern.” A “biotechnology company of concern” is a biotechnology company that is headquartered in, or subject to, the jurisdiction of a foreign adversary’s government and poses a threat to national security. The Act specifically names four Chinese companies – BGI, MGI, Complete Genomics, and WuXi AppTec – as companies of concern. The Act also provides a process for designating other companies of concern. In addition to China, the Act includes North Korea, Russia, and Iran as “foreign adversaries.”

https://www.lowenstein.com/news-insights/publications/client-alerts/the-biosecure-act-proposed-new-legislation-could-affect-us-companies-plans-to-contract-with-chinese-biotechnology-companies-life-sciences-cms

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (June 28, 2024)